Latest filing published 07 Jan 2014 for DENDREON CORP.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Bogdan Dziurzynski has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Dendreon Corp and Anthera Pharmaceuticals Inc. Between 15 June 2006 and 3 January 2014, the trades on record add up to 20 filings.
In open-market terms, that means 2 purchases worth €154k on one side and 7 sales worth €3.0M on the other. Taken together, the sales exceed the purchases by €2.9M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 7 share grants and 4 option exercises.
Most recently, on 7 January 2014, the filings show a share grant in Dendreon Corp. The last purchase on record was published on 4 June 2013, which is 4,889 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations